BSE filing, NSE: SENORES. Summary written from the filing by ALFA Finder's alert engine.
Senores Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,294.80
- Market cap
- ₹5,963 Cr
- Revenue (annual)
- ₹632.6 Cr
- Net profit (annual)
- ₹115.4 Cr
- P/E (TTM)
- 47.2×Sector 46.1×
- Promoter holding
- 45.82%+0.00% QoQ
- FII holding
- 6.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Senores Pharmaceuticals Ltd
All →Senores Pharmaceuticals Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹192.3 Cr (+24.9%), EBITDA ₹57.7 Cr (+38.3%, 30.0% margin), PAT ₹36.6 Cr. H1 revenue +30%, EBITDA +58.2%.
Senores Pharmaceuticals Results Update
Senores reported Q2 FY27 revenue of ₹192 cr and EBITDA of ₹58 cr, both record highs. PAT grew 22% Y-o-Y to ₹37 cr with positive FY27 outlook.
Senores Pharmaceuticals Capacity Expansion: ₹43 Cr Investment
Senores Pharmaceuticals disclosed capacity expansion at three subsidiaries with total estimated cost of ₹43 Crore. Expansions adding ~1.5 Bn units/annum are expected by March 2027.
- Value
- ₹43.00 Cr
- Execution
- By end of March 2027
- manufacturing capacity addition (per annum)
- 1502.7 Mn units
Senores Pharmaceuticals Q2 FY27 Results: Net Profit ₹36.6 Cr, Up 21.6% YoY
Senores Pharmaceuticals Ltd reported revenue from operations of ₹192.3 Cr (+25.0% YoY) and net profit of ₹36.6 Cr (+21.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹36.6 Cr · +21.6% YoY
Senores Pharmaceuticals Board Meeting Date
Senores Pharmaceuticals has scheduled a board meeting for October 29, 2026, to approve its unaudited financial results for the quarter and half-year ended September 30, 2026.
Senores Pharmaceuticals Annual General Meeting
Senores Pharmaceuticals Limited has issued a Postal Ballot Notice seeking shareholder approval for the re-appointment of its Managing Director and Whole Time Director. The e-voting period concludes on November 17, 2026.
Other board meeting date announcements
All →Jattashankar Industries Board Meeting Date
Jattashankar Industries will hold a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after results are announced.
Aptech Board Meeting Date
Aptech will hold a board meeting on November 4, 2026 to approve unaudited quarterly and half-year results. The trading window stays closed until 48 hours after the results are declared.
McNally Bharat Engineering Company Board Meeting Date
McNally Bharat will hold a board meeting on November 12, 2026 to approve unaudited September quarter results. The trading window stays closed until 48 hours after submission.
Shiprocket Board Meeting Date
Shiprocket will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the half year ended September 2026. The trading window stays closed until 48 hours after the outcome is declared.
Seamec Board Meeting Date
Seamec's board meets on 3 November 2026 to consider unaudited quarterly results. The results are not yet approved.
S P Capital Financing Board Meeting Date
SP Capital Financing will hold a board meeting on 4 November 2026 to consider Q2 and half-year results and an interim dividend. The record date for the interim dividend is 13 November 2026.